{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T20:10:35Z","timestamp":1773432635258,"version":"3.50.1"},"reference-count":33,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2016,3,30]],"date-time":"2016-03-30T00:00:00Z","timestamp":1459296000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0150496","type":"journal-article","created":{"date-parts":[[2016,3,30]],"date-time":"2016-03-30T22:00:37Z","timestamp":1459375237000},"page":"e0150496","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":6,"title":["Establishment of a Therapeutic Anti-Pan HLA-Class II Monoclonal Antibody That Directly Induces Lymphoma Cell Death via Large Pore Formation"],"prefix":"10.1371","volume":"11","author":[{"given":"Shuji","family":"Matsuoka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuyuki","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsuhito","family":"Nakao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaaki","family":"Abe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naomi","family":"Ohtsuji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuji","family":"Momose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisashi","family":"Arase","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Sugimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Nakauchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Masutani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michiyuki","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideo","family":"Yagita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norio","family":"Komatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Okio","family":"Hino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2016,3,30]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1056\/NEJMoa011795","article-title":"CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma","volume":"346","author":"B Coiffier","year":"2002","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/S0140-6736(10)61381-5","article-title":"Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial","volume":"376","author":"M Hallek","year":"2010","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1200\/JCO.2001.19.8.2165","article-title":"Rituximab dose-escalation trial in chronic lymphocytic leukemia","volume":"19","author":"SM O'Brien","year":"2001","journal-title":"J. Clin. Oncol."},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.3109\/10428194.2012.752080","article-title":"Pharmacogenetic analysis in the treatment of Hodgkin lymphoma","volume":"54","author":"A Alt\u00e9s","year":"2013","journal-title":"Leuk. Lymphoma"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/cncr.24005","article-title":"Therapy-related acute myelogenous leukemia and myelodysplastic syndrome in patients with acute lymphoblastic leukemia treated with the hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone regimens","volume":"115","author":"D Verma","year":"2009","journal-title":"Cancer"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1073\/pnas.79.6.2031","article-title":"Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease","volume":"79","author":"M Yoshida","year":"1982","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref7","article-title":"Clinical trials and treatment of ATL","author":"K Tsukasaki","year":"2012","journal-title":"Leuk Res Treatment"},{"key":"ref8","first-page":"2594","article-title":"Human neuroblastoma in nude mice","volume":"35","author":"L Helson","year":"1975","journal-title":"Cancer Res"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"6290","DOI":"10.1073\/pnas.95.11.6290","article-title":"A cell surface receptor defined by a mAb mediates a unique type of cell death similar to oncosis","volume":"95","author":"C Zhang","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1038\/15233","article-title":"CD47 ligation induces caspase-independent cell death in chronic lymphocytic leukemia","volume":"5","author":"V Mateo","year":"1999","journal-title":"Nat Med"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1084\/jem.181.6.2007","article-title":"A novel type of cell death of lymphocytes induced by a monoclonal antibody without participation of complement","volume":"181","author":"S Matsuoka","year":"1995","journal-title":"J Exp Med"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1084\/jem.20021301","article-title":"A monoclonal antibody to the alpha2 domain of murine major histocompatibility complex class I that specifically kills activated lymphocytes and blocks liver damage in the concanavalin A hepatitis model","volume":"198","author":"S Matsuoka","year":"2003","journal-title":"J Exp Med"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"528","DOI":"10.4161\/mabs.3.6.17770","article-title":"Lonely killers: effector cell- and complement-independent non-proapoptotic cytotoxic antibodies inducing membrane lesions","volume":"3","author":"Y Fern\u00e1ndez-Marrero","year":"2011","journal-title":"MAbs"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1097\/00007890-199208000-00017","article-title":"Mediation of skin allograft rejection in SCID mice by CD4+ and CD8+ T cells","volume":"54","author":"MW Shelton","year":"1992","journal-title":"Transplantation"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1038\/sj.onc.1209256","article-title":"Loss of interleukin-2-dependency in HTLV-I-infected T cells on gene silencing of thioredoxin-binding protein-2","volume":"25","author":"MK Ahsan","year":"2006","journal-title":"Oncogene"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"3523","DOI":"10.1182\/blood-2011-12-395541","article-title":"Antibody-induced nonapoptotic cell death in human lymphoma and leukemia cells is mediated through a novel reactive oxygen species-dependent pathway","volume":"119","author":"J Honeychurch","year":"2012","journal-title":"Blood"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/ijc.2910260605","article-title":"Two neoplastic cell lines with unique features derived from Hodgkin&apos;s disease","volume":"26","author":"M Schaadt","year":"1980","journal-title":"Int J Cancer"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1002\/1097-0142(19901201)66:11<2380::AID-CNCR2820661122>3.0.CO;2-H","article-title":"Comparative study of cutaneous T-cell lymphoma and adult T-cell leukemia\/lymphoma. Clinical, histopathologic, and immunohistochemical analyses","volume":"66","author":"T Nagatani","year":"1990","journal-title":"Cancer"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1038\/sj.leu.2400734","article-title":"Camptothecin-induced apoptosis in p53-null human leukemia HL60 cells and their isolated nuclei: effects of the protease inhibitors Z-VAD-fmk and dichlorotsocoumarin suggest an involvement of both caspases and serine proteases","volume":"11","author":"T Shimizu","year":"1997","journal-title":"Leukemia"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1006\/excr.1997.3778","article-title":"U937 apoptotic cell death by nitric oxide: Bcl-2 downregulation and caspase activation","volume":"238","author":"F Brockhaus","year":"1998","journal-title":"Exp. Cell Res"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1083\/jcb.139.6.1523","article-title":"Ligation of major histocompatability complex (MHC) class I molecules on human T cells induces cell death through PI-3 kinase-induced c-Jun NH2-terminal kinase activity: a novel apoptotic pathway distinct from Fas-induced apoptosis","volume":"139","author":"S Skov","year":"1998","journal-title":"J Cell Biol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1006\/cimm.1998.1335","article-title":"LY294002-mediated inhibition of phosphatidylinositol 3-kinase activity triggers growth inhibition and apoptosis in CD40-triggered Ramos-Burkitt lymphoma B cells","volume":"187","author":"AP Curnock","year":"1998","journal-title":"Cell Immunol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.str.2013.01.016","article-title":"Structural basis of RIP1 inhibition by necrostatin","volume":"21","author":"T Xie","year":"2013","journal-title":"Structure"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1002\/tcr.201000031","article-title":"Development of selective inhibitors of necrosis","volume":"10","author":"M Sodeoka","year":"2010","journal-title":"Chem Rec"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/0092-8674(80)90619-4","article-title":"Mechanism of action of cytochalasin B on actin","volume":"20","author":"S MacLean-Fletcher","year":"1980","journal-title":"Cell"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1126\/science.6681676","article-title":"Latrunculins: novel marine toxins that disrupt microfilament organization in cultured cells","volume":"219","author":"I Spector","year":"1983","journal-title":"Science"},{"key":"ref27","first-page":"2143","article-title":"Monoclonal antibodies directed to CD20 and HLA-DR can elicit homotypic adhesion followed by lysosome-mediated cell death in human lymphoma and leukemia cells","volume":"119","author":"A Ivanov","year":"2009","journal-title":"J Clin Invest"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"3629","DOI":"10.1182\/blood.V90.9.3629","article-title":"Fas-independent apoptosis of activated T cells induced by antibodies to the HLA class I alpha1 domain","volume":"90","author":"L Geneistier","year":"1997","journal-title":"Blood"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"5060","DOI":"10.1074\/jbc.273.9.5060","article-title":"Caspase-dependent ceramide production in Fas- and HLA class I-mediated peripheral T cell apoptosis","volume":"273","author":"L Genestier","year":"1998","journal-title":"J Biol Chem"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1093\/intimm\/6.6.887","article-title":"Lymphocyte programmed cell death is mediated via HLA class II DR","volume":"6","author":"JP Truman","year":"1994","journal-title":"Int Immunol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/nm736","article-title":"Fully human, HLA-DR-specific monoclonal antibodies efficiently induce programmed death of malignant lymphoid cells","volume":"8","author":"ZA Nagy","year":"2002","journal-title":"Nat Med"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s12185-011-0941-5","article-title":"Antibody therapy for Adult T-cell leukemia-lymphoma","volume":"94","author":"T Ishida","year":"2011","journal-title":"Int J Hematol"},{"issue":"5","key":"ref33","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/bjh.13338","article-title":"Dose-intensified chemotherapy alone or in combination with mogamulizumab in newly diagnosed aggressive adult T-cell leukaemia-lymphoma: a randomized phase II study","volume":"169","author":"T Ishida","year":"2015","journal-title":"Br J Haematol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0150496","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,17]],"date-time":"2020-09-17T23:47:52Z","timestamp":1600386472000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0150496"}},"subtitle":[],"editor":[{"given":"Francesco","family":"Bertolini","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2016,3,30]]},"references-count":33,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2016,3,30]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0150496","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,30]]}}}